Investors of Indian pharmaceutical companies are worried about the prospect of further escalation amid U.S. trade tensions.

Crisil Intelligence warns US tariffs pose a major risk to India's growth, impacting exports & investments. Domestic ...

High tariffs imposed by the United States on Indian goods pose a major risk to the country’s growth, Crisil Intelligence said ...

US tariffs on patented drugs won’t hit Indian pharma immediately, says Bhaskar Chakravorti, but future risk to generics ...

The latest wave of tariffs will take effect on October 1. Earlier, the Ministry of External Affairs (MEA) said it is ...

NATO Secretary General Mark Rutte Thursday suggested that Trump’s tariffs on India led to New Delhi pressuring the Russian ...

From the start of October, imported branded drugs will face a steep 100 per cent duty, while heavy-duty trucks will carry a ...

Trump’s tariffs have given India’s economy a sharp shock, forcing it to confront its vulnerabilities and accelerate ...

While Trump’s latest decision does not impact India much, the fast-changing tariff policies of the US are enough to induce ...

When multilateralism is under stress, BRICS has stood firm as a strong voice of reason and constructive change,” Jaishankar said in a social media post.

India is pressing the US for tariffs below 20% and removal of the 25% levy on Russian oil purchases. Jaishankar flagged ...

Taiwan is seeking to double its exports of chips and electronics to India over the next five to seven years as smartphone ...